 Antihypertensive Agents
"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
| Descriptor ID |
D000959
|
| MeSH Number(s) |
D27.505.954.411.162
|
| Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1985 | 0 | 1 | 1 | | 1986 | 1 | 0 | 1 | | 1987 | 0 | 1 | 1 | | 1988 | 0 | 1 | 1 | | 1989 | 1 | 1 | 2 | | 1990 | 2 | 0 | 2 | | 1991 | 1 | 1 | 2 | | 1992 | 1 | 0 | 1 | | 1993 | 3 | 6 | 9 | | 1994 | 3 | 1 | 4 | | 1995 | 2 | 2 | 4 | | 1996 | 7 | 4 | 11 | | 1997 | 4 | 1 | 5 | | 1998 | 7 | 3 | 10 | | 1999 | 4 | 3 | 7 | | 2000 | 10 | 3 | 13 | | 2001 | 7 | 4 | 11 | | 2002 | 13 | 4 | 17 | | 2003 | 14 | 9 | 23 | | 2004 | 11 | 9 | 20 | | 2005 | 14 | 4 | 18 | | 2006 | 15 | 3 | 18 | | 2007 | 18 | 5 | 23 | | 2008 | 20 | 4 | 24 | | 2009 | 20 | 10 | 30 | | 2010 | 16 | 14 | 30 | | 2011 | 16 | 9 | 25 | | 2012 | 19 | 7 | 26 | | 2013 | 22 | 8 | 30 | | 2014 | 11 | 6 | 17 | | 2015 | 17 | 5 | 22 | | 2016 | 12 | 5 | 17 | | 2017 | 13 | 10 | 23 | | 2018 | 20 | 10 | 30 | | 2019 | 10 | 4 | 14 | | 2020 | 5 | 6 | 11 | | 2021 | 9 | 10 | 19 | | 2022 | 0 | 7 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Tran PM, Tran LT, Zhu C, Chang T, Powers IP, Goldstein LB, Lichtman JH. Rural Residence and Antihypertensive Medication Use in US Stroke Survivors. J Am Heart Assoc. 2022 08 02; 11(15):e026678.
-
Goldstein ED, Wolcott Z, Garg G, Navarro K, Delic A, Yaghi S, Sederholm B, Prabhakaran S, Wong KH, McLean K, de Havenon AH. Effect of Antihypertensives by Class on Cerebral Small Vessel Disease: A Post Hoc Analysis of SPRINT-MIND. Stroke. 2022 08; 53(8):2435-2440.
-
de Havenon A, Sharma R, Falcone GJ, Prabhakaran S, Sheth KN. Effect of Intensive Blood Pressure Control on Incident Stroke Risk in Patients With Mild Cognitive Impairment. Stroke. 2022 07; 53(7):e242-e245.
-
Thomeas-McEwing V, Psotka MA, Gamazon ER, Friedman P, Konkashbaev A, Kubo M, Nakamura Y, Ratain MJ, Benza RL, Cox NJ, Gomberg-Maitland MI, Maitland ML. Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension. Pharmacogenet Genomics. 2022 06 01; 32(4):144-151.
-
de Havenon A, Petersen N, Wolcott Z, Goldstein E, Delic A, Sheibani N, Anadani M, Sheth KN, Lansberg M, Turan T, Prabhakaran S. Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022 03 01; 40(3):462-469.
-
van Kleef MEAM, Devireddy CM, van der Heyden J, Bates MC, Bakris GL, Stone GW, Williams B, Spiering W. Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM Study. JACC Cardiovasc Interv. 2022 02 14; 15(3):321-332.
-
McNavish DE, German CA, Shapiro MD. Should a Statin be Given to All Hypertensive Patients? Curr Hypertens Rep. 2022 01; 24(1):21-27.
-
Nwabueze N, Docheva N, Arenas G, Mueller A, Lopes Perdigao J, Rana S. Prevalence and management of severe intrapartum hypertension in patients with preeclampsia at an urban tertiary care medical center. Pregnancy Hypertens. 2022 Mar; 27:87-93.
-
Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, Rana S, Vermunt JV, August P. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022 02; 79(2):e21-e41.
-
Egan BM, Yang J, Rakotz MK, Sutherland SE, Jamerson KA, Wright JT, Ferdinand KC, Wozniak GD. Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines. Hypertension. 2022 02; 79(2):338-348.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|